Genmab — Maj 2020
-
Janssen, which obtained an exclusive worldwide license to develop, manufacture and commercialize daratumumab from Genmab in 2012, will discuss with health authorities the potential for a regulatory submission for this indication.
-
That must be health authorities worldwide I presume?
-
Mon den holder + i dag?
-
sure..
-
14:00 CET. Leading oncologists will surely post results on twitter shortly after
-
Beginning Friday, May 29 at 8:00 AM ET
Oral, Poster Discussion, and Poster Sessions, as well as track-based Clinical Science Symposia, will be available on demand.
Registrants will have exclusive access to hundreds of video and slide presentations, as well as discussant commentary for 180 days -
hvordan åbner man chat vinduet på iphone?
-
har fundet den
-
ja, men jeg skulle først trykke på "åbn chat", det var det jeg ikke kunne huske, eller tak
-
small New trial : Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab https://www.clinicaltrials.gov/ct2/show/NCT04407442?cond=Multiple+Myeloma&sfpd_s=05%2F15%2F2020&sfpd_d=14&sel_rss=new14
-CD3xCD20) Phase 1/2 dose-escalation study on Friday May 29 at 8 AM EDT.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind